Abbott Laboratories logo

Abbott Laboratories - Cedear

NEW
BUE:ABT (USA)   Cedear
ARS 39,640 +940 (+2.43%) Jul 17
28.20
P/B:
3.37
Market Cap:
ARS 259.21T ($ 174.99B)
Enterprise V:
ARS 299.69T ($ 202.32B)
Volume:
6.14K
Avg Vol (2M):
4.25K
Trade In:
Volume:
6.14K
Avg Vol (2M):
4.25K

Abbott Laboratories’s share price is ARS39640. Its GF Value is ARS50147.11. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Abbott Laboratories stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: ARS39640 GF Value Price/GF Value
Current ARS50147.11 0.79
Next FY1 End ARS56345.92 0.70
Next 12 Month ARS59199.28 0.67
Next FY2 End ARS61258.54 0.65
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Abbott Laboratories's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Abbott Laboratories's stock price and Book Value per share, with a coefficient of 94%. This is followed by a 92% correlation with Revenue per share and a 90% correlation with Operating Cash Flow per share. The weakest correlation is observed with Operating Cash Flow per share, at 90%.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies